AIM ImmunoTech Announces SITC 2025 Late-Breaking Abstract
AIM ImmunoTech (NYSE American: AIM) announced that data from a…
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery
Rani Therapeutics, LLC SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…